SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Bal Pharma informs about newspaper publication

18 Nov 2019 Evaluate

Bal Pharma has informed that it has enclosed published Un-audited financial results for the quarter and half year ended 30/09/2019 in Financial Express (English) and Sanjayvani (Kannada), on 16th November 2019.

The above information is a part of company’s filings submitted to BSE.

Bal Pharma Share Price

87.40 1.34 (1.56%)
11-Jun-2026 11:25 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1793.15
Dr. Reddys Lab 1280.50
Cipla 1385.90
Zydus Lifesciences 1099.15
Lupin 2272.30
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×